Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00630292 · ClinicalTrials.gov registry record · NA

Feasibility Study of Vessel Analysis for Noninvasive Diagnosis of Malignancy in Breast Tumors

A NA study, sponsored by University of North Carolina, Chapel Hill.

Terminated
Registry status
NA
Development phase
6
Enrollment target

NCT00630292: Clinical Trial NA study, sponsored by University of North Carolina, Chapel Hill.

NCT00630292 is a NA study that was terminated before completion, run by University of North Carolina, Chapel Hill. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00630292, a NA study, was terminated before completion, sponsored by University of North Carolina, Chapel Hill.

TERMINATED
Registry status
NA
Development phase
6 participants
Enrollment target

Study Summary

This is a pilot study designed to explore the feasibility of non-invasively diagnosing the presence of cancer in the breast using non-invasive magnetic resonance imaging (MRI) methods and an analysis of vessel shape defined from these magnetic resonance images.

Primary Outcome

Amount of vessel tortuosity before the start of neoadjuvant chemotherapy and at the end of neoadjuvant chemotherapy

Interventions

  • OTHER Magnetic Resonance Angiography (MRA) of the Breast

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2008-03
Est. Completion 2009-12
Phase NA

Why NCT00630292 stopped before completion

NCT00630292 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Magnetic Resonance Angiography (MRA) of the Breast is the first listed.

NCT00630292 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00630292 about?

NCT00630292 is a clinical study titled "Feasibility Study of Vessel Analysis for Noninvasive Diagnosis of Malignancy in Breast Tumors". This is a pilot study designed to explore the feasibility of non-invasively diagnosing the presence of cancer in the breast using non-invasive magnetic resonance imaging (MRI) methods and an analysis of vessel shape defined from these magnetic resonance images.

What is the current status of trial NCT00630292?

This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2008-03. Estimated completion is 2009-12.

What interventions are being tested in trial NCT00630292?

The interventions under investigation include: Magnetic Resonance Angiography (MRA) of the Breast (OTHER).

Who is sponsoring clinical trial NCT00630292?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00630292's enrollment target sits among peer trials

6 1983rd of 2000 higher than 13 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00630292, the US trial registry maintained by the National Library of Medicine. NCT00630292 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.